Science & Technology

Corporate Office


Facility Location


Greenhouse Size

4.3 M FT2/40 HA

Projected Capacity

537,500 KG/ANNUM

Asterion has entered into a collaborative research contract with the Queensland Alliance for Agriculture and Food Innovation (“QAAFI”) at the University of Queensland consisting of an eighteen month, ‘proof-of-concept’ clonal propagation research program. 

The aim will be to expedite clonal propagation of elite selections of cannabis plants to enable high volume, uniform plant cultivation that will be required to serve the rapidly growing demand for cannabis-based medicines for a wide and expanding variety of ailments. The outcome will develop proof of concept for in vitro propagation of the selected cultivars.  

The research will identify and establish a proprietary, genetically stable, repeatable, high yield tissue propagation procedure for a number of cannabis strains.  The use of tissue culture will provide a pathogen-free source of stable genetics, eliminating the need for mothers and manual cloning procedures.  The intellectual property generated through the research will be wholly owned by Asterion, creating a suite of technologies and procedures absolutely necessary for large scale cannabis facilities.   

May 16, 2019

Asterion Invited to Participate in the Cowen Toronto Cannabis Summit

arrowRead More
May 6, 2019

Asterion Announces $25 Million Private Placement

arrowRead More
April 24, 2019

Asterion Signs Land Purchase Agreement for 75 Hectares of Land for its Queensland Medicinal Cannabis Facility

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?